| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1107228588 |
| P356 | DOI | 10.1186/S40249-018-0481-9 |
| P932 | PMC publication ID | 6156959 |
| P698 | PubMed publication ID | 30253788 |
| P50 | author | Luc E Coffeng | Q55188920 |
| Sake J de Vlas | Q63100920 | ||
| Wilma A Stolk | Q89944622 | ||
| Natalie V S Vinkeles Melchers | Q91732557 | ||
| Michael Edlinger | Q50947621 | ||
| P2093 | author name string | Robert Colebunders | |
| Andrea S Winkler | |||
| Joseph N Siewe | |||
| Julia Irani | |||
| Sarah Mollenkopf | |||
| Trésor Zola | |||
| P2860 | cites work | High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin. | Q55360111 |
| Epilepsy in resource poor countries--suggestion of an adjusted classification | Q80349704 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 | Q27468570 | ||
| The prevalence of epilepsy follows the distribution of onchocerciasis in a west Ugandan focus | Q27486534 | ||
| Epilepsy and retarded growth in a hyperendemic focus of onchocerciasis in rural western Uganda | Q28239886 | ||
| African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost | Q28485398 | ||
| Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. | Q30485861 | ||
| Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda | Q31061763 | ||
| Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys | Q33468406 | ||
| Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections | Q33681574 | ||
| Exposure to multiple parasites is associated with the prevalence of active convulsive epilepsy in sub-Saharan Africa | Q33685560 | ||
| Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus | Q33697662 | ||
| A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy | Q33745218 | ||
| Global disparities in the epilepsy treatment gap: a systematic review | Q33793327 | ||
| The challenges of managing children with epilepsy in Africa | Q33870131 | ||
| Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa | Q33871497 | ||
| Epilepsy treatment in sub-Saharan Africa: closing the gap. | Q34305405 | ||
| Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study | Q34320867 | ||
| The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected | Q34465622 | ||
| Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis | Q34654304 | ||
| Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae | Q34675134 | ||
| The global burden and stigma of epilepsy | Q34750940 | ||
| Association between onchocerciasis and epilepsy in the Itwara hyperendemic focus, West Uganda: controlling for time and intensity of exposure | Q35131365 | ||
| Prevalence of River Epilepsy in the Orientale Province in the Democratic Republic of the Congo | Q36006747 | ||
| Health care utilization and outpatient, out-of-pocket costs for active convulsive epilepsy in rural northeastern South Africa: a cross-sectional Survey | Q36063557 | ||
| Epilepsy-associated stigma in sub-Saharan Africa: the social landscape of a disease | Q36175039 | ||
| Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis | Q36201881 | ||
| An estimate of the prevalence of epilepsy in Sub-Saharan Africa: A systematic analysis | Q36485978 | ||
| The cost of implementing a nationwide program to decrease the epilepsy treatment gap in a high gap country | Q36562942 | ||
| The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies | Q36612330 | ||
| Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies | Q36637008 | ||
| An exploration of caregiver burden for children with nodding syndrome (lucluc) in Northern Uganda | Q37118006 | ||
| Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study | Q37152586 | ||
| Nodding syndrome in Mundri county, South Sudan: environmental, nutritional and infectious factors | Q37299128 | ||
| Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management | Q37733228 | ||
| Diagnostic criteria for neurocysticercosis, revisited | Q38069636 | ||
| Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial | Q38372017 | ||
| The Mectizan Donation Program (MDP). | Q38440380 | ||
| High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo | Q38678864 | ||
| 'These nodding people': Experiences of having a child with nodding syndrome in postconflict Northern Uganda | Q38860539 | ||
| High prevalence of epilepsy in a village in the Littoral Province of Cameroon | Q38875368 | ||
| Epilepsy, retarded growth and onchocerciasis, in two areas of different endemicity of onchocerciasis in Burundi. | Q38887543 | ||
| Nodding Syndrome in Onchocerciasis Endemic Areas | Q38950251 | ||
| Nodding syndrome: Preventable and treatable | Q39137453 | ||
| Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. | Q41689467 | ||
| Onchocerciasis and epilepsy in Uganda | Q43850233 | ||
| Ocular onchocerciasis and intensity of infection in the community. III. West African rainforest foci of the vector Simulium sanctipauli | Q43936414 | ||
| Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. | Q46013604 | ||
| Relationship between onchocerciasis and epilepsy: a matched case-control study in the Mbam Valley, Republic of Cameroon | Q46259778 | ||
| Epilepsy treatment gap: prevalence and associated factors in Southeast Nigeria | Q46321328 | ||
| Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon | Q46546709 | ||
| Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru | Q46618700 | ||
| Onchocerciasis and epilepsy in parts of the Imo river basin, Nigeria: a preliminary report. | Q46793562 | ||
| Onchocerciasis-Associated Epilepsy, an Additional Reason for Strengthening Onchocerciasis Elimination Programs | Q49486176 | ||
| Economic burden of epilepsy in India. | Q50682892 | ||
| Improvement in seizures after ivermectin | Q52441726 | ||
| Magnitude and factors associated with nonadherence to antiepileptic drug treatment in Africa: A cross-sectional multisite study. | Q53070638 | ||
| Onchocerciasis-associated epilepsy: From recent epidemiological and clinical findings to policy implications. | Q53697858 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epilepsy | Q41571 |
| onchocerciasis | Q1137321 | ||
| cost of illness | Q66969671 | ||
| research priority | Q119852497 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 101 | |
| P577 | publication date | 2018-09-19 | |
| P1433 | published in | Infectious Diseases of Poverty | Q27724786 |
| P1476 | title | Burden of onchocerciasis-associated epilepsy: first estimates and research priorities | |
| P478 | volume | 7 |
| Q92627071 | "Running the Gauntlet": Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a "Call to Action" |
| Q61797172 | Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys |
| Q90234620 | Economic evaluations of onchocerciasis interventions: a systematic review and research needs |
| Q91989289 | From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes |
| Q91740173 | Nodding syndrome research, lessons learned from the NSETHIO project |
| Q64282544 | Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania |
| Q64266737 | Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group |
| Q99591362 | Zoonotic Implications of Onchocerca Species on Human Health |
Search more.